Topics

Human medicines European public assessment report (EPAR): Telmisartan Teva Pharma, telmisartan, Hypertension, Date of authorisation: 03/10/2011, Revision: 8, Status: Authorised

11:20 EST 7 Nov 2019 | European Medicines Agency

Human medicines European public assessment report (EPAR): Telmisartan Teva Pharma, telmisartan, Hypertension, Date of authorisation: 03/10/2011, Revision: 8, Status: Authorised

Original Article: Human medicines European public assessment report (EPAR): Telmisartan Teva Pharma, telmisartan, Hypertension, Date of authorisation: 03/10/2011, Revision: 8, Status: Authorised

NEXT ARTICLE

More From BioPortfolio on "Human medicines European public assessment report (EPAR): Telmisartan Teva Pharma, telmisartan, Hypertension, Date of authorisation: 03/10/2011, Revision: 8, Status: Authorised"

Quick Search

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...